![]() |
Name |
GKK1032B
|
Molecular Formula | C32H39NO4 | |
IUPAC Name* |
(3S,4R,5S,7R,9S,10S,13S,14R,16R,20S,27S)-13-ethenyl-5,7,9,11,13-pentamethyl-2-oxa-18-azahexacyclo[20.2.2.13,10.04,9.016,20.014,27]heptacosa-1(25),11,22(26),23-tetraene-15,17,19-trione
|
|
SMILES |
C[C@@H]1C[C@@H]([C@H]2[C@@H]3[C@H]4[C@H]([C@@]2(C1)C)C(=C[C@]([C@@H]4C(=O)[C@H]5[C@H](CC6=CC=C(O3)C=C6)C(=O)NC5=O)(C)C=C)C)C
|
|
InChI |
InChI=1S/C32H39NO4/c1-7-31(5)15-18(4)24-23-26(31)27(34)22-21(29(35)33-30(22)36)13-19-8-10-20(11-9-19)37-28(23)25-17(3)12-16(2)14-32(24,25)6/h7-11,15-17,21-26,28H,1,12-14H2,2-6H3,(H,33,35,36)/t16-,17+,21+,22-,23+,24-,25+,26+,28+,31+,32+/m1/s1
|
|
InChIKey |
GAPPHVJLWSRLAC-ZABYPXOYSA-N
|
|
Synonyms |
GKK1032B; 358375-11-8; (3S,4R,5S,7R,9S,10S,13S,14R,16R,20S,27S)-13-ethenyl-5,7,9,11,13-pentamethyl-2-oxa-18-azahexacyclo[20.2.2.13,10.04,9.016,20.014,27]heptacosa-1(25),11,22(26),23-tetraene-15,17,19-trione; (3aR,9aR,9bS,10R,12S,13aR,13bR,13cR,16R,16aS,17aS)-rel-(+)-16-ethenyl-3a,9b,10,11,12,13,13a,13b,13c,16,16a,17a-dodecahydro-10,12,13a,14,16-<wbbr/>pentamethyl-5,8-ethenofluoreno[9',1':2,3,4]oxacyclododecino[6,7-c]pyrrole-1,3,17(2H,4H,9aH)-trione; HY-N8498; CS-0145018
|
|
CAS | NA | |
PubChem CID | 134865937 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 501.7 | ALogp: | 6.2 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 72.5 | Aromatic Rings: | 7 |
Heavy Atoms: | 37 | QED Weighted: | 0.315 |
Caco-2 Permeability: | -5.228 | MDCK Permeability: | 0.00002430 |
Pgp-inhibitor: | 0.542 | Pgp-substrate: | 0.111 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.011 | Plasma Protein Binding (PPB): | 100.66% |
Volume Distribution (VD): | 1.549 | Fu: | 1.50% |
CYP1A2-inhibitor: | 0.166 | CYP1A2-substrate: | 0.444 |
CYP2C19-inhibitor: | 0.701 | CYP2C19-substrate: | 0.462 |
CYP2C9-inhibitor: | 0.843 | CYP2C9-substrate: | 0.948 |
CYP2D6-inhibitor: | 0.884 | CYP2D6-substrate: | 0.178 |
CYP3A4-inhibitor: | 0.947 | CYP3A4-substrate: | 0.744 |
Clearance (CL): | 8.416 | Half-life (T1/2): | 0.019 |
hERG Blockers: | 0.189 | Human Hepatotoxicity (H-HT): | 0.812 |
Drug-inuced Liver Injury (DILI): | 0.935 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.929 | Maximum Recommended Daily Dose: | 0.955 |
Skin Sensitization: | 0.112 | Carcinogencity: | 0.121 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.883 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004853 | ![]() |
0.714 | D0W2EK | ![]() |
0.225 | ||
ENC003989 | ![]() |
0.656 | D07DIM | ![]() |
0.218 | ||
ENC003773 | ![]() |
0.591 | D0VA0I | ![]() |
0.213 | ||
ENC003240 | ![]() |
0.591 | D09HNR | ![]() |
0.209 | ||
ENC004852 | ![]() |
0.585 | D0V4WD | ![]() |
0.209 | ||
ENC003349 | ![]() |
0.578 | D06XZW | ![]() |
0.205 | ||
ENC005320 | ![]() |
0.577 | D0L7LC | ![]() |
0.205 | ||
ENC003137 | ![]() |
0.566 | D0KR9U | ![]() |
0.204 | ||
ENC003851 | ![]() |
0.556 | D0F1EX | ![]() |
0.204 | ||
ENC003606 | ![]() |
0.411 | D0TG7I | ![]() |
0.203 |